Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#171 / 200 Total
QLGN - Qualigen Therapeutics Inc - Stock Price Chart
TickerQLGN [NASD]
CompanyQualigen Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.75MEPS (ttm)-55.30
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y71.09%
P/S-EPS next 5Y-
P/B-EPS Q/Q84.37%
Dividend-Sales Q/Q-
Insider Own6.96%Inst Own1.17%
Insider Trans0.00%Inst Trans-17.81%
Short Float4.28%Earnings-
Analyst Recom1.00Target Price250.00
Avg Volume57.93K52W Range2.85 - 29.43
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.
CRK - Comstock Resources, Inc - Stock Price Chart
TickerCRK [NYSE, RUT]
CompanyComstock Resources, Inc
CountryUSA
IndustryOil & Gas E&P
Market Cap9.00BEPS (ttm)-1.12
P/E-EPS this Y426.05%
Forward P/E21.10EPS next Y86.16%
PEG-EPS past 5Y-
P/S6.51EPS next 5Y-
P/B4.24EPS Q/Q-611.75%
Dividend-Sales Q/Q52.74%
Insider Own73.32%Inst Own30.07%
Insider Trans-0.02%Inst Trans-2.80%
Short Float26.07%EarningsApr 30/a
Analyst Recom3.11Target Price21.19
Avg Volume2.25M52W Range7.74 - 28.88
Comstock Resources, Inc. engages in the acquisition, development, and exploration of oil and natural gas. The firm operations concentrated in the Haynesville shale, a premier natural gas basin located in East Texas. The company was founded in 1919 and is headquartered in Frisco, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanders LaRae LynnVice President of LandJun 14 '25Option Exercise0.0014,8830249,881Jun 17 04:27 PM
PRESLEY DANIEL KVP of AccountingJun 14 '25Option Exercise0.0015,8110264,024Jun 17 04:27 PM
Newell Clifford Doyle IIIChief Commercial OfficerJun 14 '25Option Exercise0.0019,4480108,904Jun 17 04:27 PM
Mills Ronald EugeneVP of Finance. and IRJun 14 '25Option Exercise0.0013,0450139,124Jun 17 04:27 PM
McGough PatrickVice President of OperationsJun 14 '25Option Exercise0.0015,8720231,865Jun 17 04:26 PM
AVTX - Avalo Therapeutics Inc - Stock Price Chart
TickerAVTX [NASD]
CompanyAvalo Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap51.54MEPS (ttm)-21.53
P/E-EPS this Y76.25%
Forward P/E-EPS next Y1.59%
PEG-EPS past 5Y56.49%
P/S117.14EPS next 5Y39.73%
P/B0.42EPS Q/Q99.11%
Dividend-Sales Q/Q-
Insider Own20.47%Inst Own62.85%
Insider Trans0.00%Inst Trans34.42%
Short Float0.54%EarningsMay 12/b
Analyst Recom1.00Target Price29.88
Avg Volume71.40K52W Range3.39 - 16.00
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Almenoff June SherieDirectorNov 13 '24Buy13.005006,5001,000Nov 14 05:21 PM
Almenoff June SherieDirectorNov 12 '24Buy12.505006,250500Nov 14 05:21 PM
KFY - Korn Ferry - Stock Price Chart
TickerKFY [NYSE, RUT]
CompanyKorn Ferry
CountryUSA
IndustryStaffing & Employment Services
Market Cap3.67BEPS (ttm)4.62
P/E15.39EPS this Y5.82%
Forward P/E12.49EPS next Y10.17%
PEG1.61EPS past 5Y19.40%
P/S1.33EPS next 5Y9.57%
P/B1.96EPS Q/Q-2.75%
Dividend2.53%Sales Q/Q2.84%
Insider Own1.44%Inst Own96.97%
Insider Trans0.00%Inst Trans-2.61%
Short Float2.63%EarningsJun 18/b
Analyst Recom1.60Target Price83.75
Avg Volume434.45K52W Range59.23 - 80.64
Korn Ferry is a global organizational consulting firm, which engages in synchronizing its clients' strategy, operations, and talent to drive superior business performance. It operates through the following segments: Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search Asia Pacific, Executive Search Latin America, and RPO and Professional Search. The Consulting segment aligns organization structure, culture, performance, and people to drive sustainable growth by addressing four fundamental needs, which include Organizational Strategy, Assessment and Succession, Leadership and Professional Development, and Total Rewards. The Digital segment leverages an artificial intelligence powered, machine-learning platform to identify the best structures, roles, capabilities, and behaviors needed to drive business forward. The Executive Search segment helps organizations recruit board level, chief executive, and other senior executive and general management talent. The RPO and Professional Search segment combines people, process expertise and IP-enabled technology to deliver enterprise talent acquisition solutions to clients. The company was founded by Richard M. Ferry on November 14, 1969 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arian MarkCEO of ConsultingDec 11 '24Sale72.2420,0001,444,86068,869Dec 18 06:05 AM
Mark D Arian 2024 Revocable TrOfficerDec 11 '24Proposed Sale72.0020,0001,440,000Dec 11 04:21 PM
PERRY DEBRA JDirectorOct 15 '24Sale73.305,280387,04146,180Oct 16 04:05 PM
Debra Perry Board Member Oct 15 '24Proposed Sale73.435,280387,710Oct 15 02:06 PM
BURNISON GARY DCEOOct 02 '24Sale73.6845,0003,315,600311,844Oct 03 07:07 PM
CARS - Cars.com - Stock Price Chart
TickerCARS [NYSE, RUT]
CompanyCars.com
CountryUSA
IndustryInternet Content & Information
Market Cap685.46MEPS (ttm)0.67
P/E16.22EPS this Y0.60%
Forward P/E5.12EPS next Y23.84%
PEG1.82EPS past 5Y-
P/S0.95EPS next 5Y8.92%
P/B1.42EPS Q/Q-368.97%
Dividend-Sales Q/Q-0.64%
Insider Own9.71%Inst Own92.68%
Insider Trans0.46%Inst Trans-2.46%
Short Float6.90%EarningsMay 08/b
Analyst Recom2.14Target Price16.21
Avg Volume856.17K52W Range9.56 - 21.24
Cars.com, Inc. engages in the provision of an automotive marketplace platform and digital solutions that connect car shoppers with sellers. Its portfolio of brands includes Dealer Inspire, FUEL, DealerRater, CreditIQ, and NewCars.com. The company was founded by Mitch Golub, William Swislow, and T. Alex Vetter in 1998 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vetter Thomas AlexCEOMay 09 '25Buy10.7527,870299,558844,897May 12 12:33 PM
Greenthal Jill ADirectorDec 02 '24Sale19.8510,990218,15290,973Dec 04 04:30 PM
Greenthal Jill ADirectorDec 02 '24Proposed Sale19.8010,990217,603Dec 02 07:07 PM
Greenthal Jill ADirectorNov 26 '24Sale19.864,52489,847101,963Nov 29 05:00 PM
Jain SoniaChief Financial OfficerNov 26 '24Sale19.7424,971492,928229,229Nov 29 05:00 PM
SOFI - SoFi Technologies Inc - Stock Price Chart
TickerSOFI [NASD]
CompanySoFi Technologies Inc
CountryUSA
IndustryCredit Services
Market Cap16.98BEPS (ttm)0.42
P/E36.50EPS this Y-29.46%
Forward P/E29.22EPS next Y91.10%
PEG1.50EPS past 5Y-
P/S4.36EPS next 5Y24.31%
P/B2.54EPS Q/Q179.17%
Dividend-Sales Q/Q14.17%
Insider Own2.12%Inst Own46.57%
Insider Trans-1.55%Inst Trans0.19%
Short Float13.33%EarningsApr 29/b
Analyst Recom2.73Target Price14.09
Avg Volume62.08M52W Range6.01 - 18.42
SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rishel JeremyOfficerJun 17 '25Proposed Sale14.66140,4942,059,333Jun 17 03:36 PM
Simcock StephenOfficerJun 17 '25Proposed Sale14.6638,222560,250Jun 17 03:33 PM
Keough KelliOfficerJun 17 '25Proposed Sale14.6659,962878,911Jun 17 03:28 PM
White Derek JOfficerJun 17 '25Proposed Sale14.6664,467944,944Jun 17 03:19 PM
Pinto ArunOfficerJun 17 '25Proposed Sale14.665,61182,245Jun 17 03:12 PM
SEDG - Solaredge Technologies Inc - Stock Price Chart
TickerSEDG [NASD]
CompanySolaredge Technologies Inc
CountryIsrael
IndustrySolar
Market Cap1.00BEPS (ttm)-30.14
P/E-EPS this Y85.61%
Forward P/E-EPS next Y84.94%
PEG-EPS past 5Y-
P/S1.06EPS next 5Y-
P/B1.67EPS Q/Q38.43%
Dividend-Sales Q/Q7.38%
Insider Own2.48%Inst Own98.52%
Insider Trans2.09%Inst Trans-1.69%
Short Float31.53%EarningsMay 06/b
Analyst Recom3.48Target Price15.15
Avg Volume5.01M52W Range10.24 - 38.48
SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov in 2006 and is headquartered in Herzliya, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AVERY MOREChairman of the BoardMar 04 '25Buy13.7030,000411,000274,478Mar 06 11:56 AM
GANI MARCELDirectorNov 13 '24Buy11.4320,000228,64853,035Nov 14 04:01 PM
AVERY MOREChairman of the BoardNov 11 '24Buy13.65156,0002,129,400244,478Nov 13 03:06 PM
INOD - Innodata Inc - Stock Price Chart
TickerINOD [NASD, RUT]
CompanyInnodata Inc
CountryUSA
IndustryInformation Technology Services
Market Cap1.47BEPS (ttm)1.04
P/E44.55EPS this Y-22.02%
Forward P/E45.63EPS next Y46.31%
PEG3.31EPS past 5Y-
P/S7.27EPS next 5Y13.46%
P/B19.48EPS Q/Q625.73%
Dividend-Sales Q/Q120.13%
Insider Own4.49%Inst Own60.60%
Insider Trans-23.44%Inst Trans14.58%
Short Float17.42%EarningsMay 08/a
Analyst Recom1.20Target Price64.40
Avg Volume2.01M52W Range12.67 - 71.00
Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FORLENZA LOUISE CDirectorMar 17 '25Option Exercise7.241,0007,2409,278Mar 17 04:40 PM
FORLENZA LOUISE CDirectorMar 17 '25Sale50.151,00050,1508,278Mar 17 04:40 PM
LOUISE FORLENZADirectorMar 17 '25Proposed Sale50.151,00050,146Mar 17 04:12 PM
FORLENZA LOUISE CDirectorMar 03 '25Option Exercise7.245,00036,20013,278Mar 04 04:20 PM
FORLENZA LOUISE CDirectorMar 03 '25Sale52.925,000264,6008,278Mar 04 04:20 PM
INM - InMed Pharmaceuticals Inc - Stock Price Chart
TickerINM [NASD]
CompanyInMed Pharmaceuticals Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap3.03MEPS (ttm)-12.63
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y53.87%
P/S0.62EPS next 5Y-
P/B0.43EPS Q/Q46.01%
Dividend-Sales Q/Q7.59%
Insider Own0.39%Inst Own7.19%
Insider Trans0.00%Inst Trans-35.49%
Short Float4.13%EarningsMay 13/b
Analyst Recom3.00Target Price400.00
Avg Volume1.31M52W Range1.72 - 15.70
InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around the research and development of small molecule pharmaceuticals drug candidates. The BayMedica segment focuses on the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANCINI ALEXANDRA DIANE JANETConsultantJul 31 '24Sale0.18240420Aug 02 04:02 PM
SION - Sionna Therapeutics Inc - Stock Price Chart
TickerSION [NASD]
CompanySionna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap649.95MEPS (ttm)-
P/E-EPS this Y83.43%
Forward P/E-EPS next Y-8.40%
PEG-EPS past 5Y-
P/S-EPS next 5Y40.90%
P/B1.85EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own46.56%Inst Own51.52%
Insider Trans20.32%Inst Trans37.11%
Short Float12.18%EarningsMay 12/b
Analyst Recom1.00Target Price38.50
Avg Volume166.21K52W Range7.26 - 25.19
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TPG GP A, LLC10% OwnerFeb 10 '25Buy18.001,125,00020,250,0006,684,962Feb 12 05:21 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 10 '25Buy18.001,125,00020,250,0006,923,365Feb 10 05:04 PM
ORBIMED ADVISORS LLCDirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:28 PM
Thompson Peter A.DirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:05 PM
Booth BruceDirectorFeb 10 '25Buy18.0060,0001,080,000807,727Feb 10 04:05 PM
1101314151617181920